The changing global patterns of female breast cancer incidence and mortality

Breast Cancer Research

Volumn 6, Issue 6, 2004, Pages 229-239

  Bray, Freddie ^a   McCarron, Peter ^b   Parkin, D Maxwell ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast neoplasms; Cancer registries; Epidemiology; Incidence; Mortality; Time trends

Indexed keywords

AROMATASE INHIBITOR; RALOXIFENE; TAMOXIFEN;

AGE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; CLINICAL TRIAL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAMMOGRAPHY; MASTECTOMY; META ANALYSIS; MORTALITY; PREVALENCE; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MORBIDITY;

EID: 7444265760     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr932     Document Type: Review

References (85)

1. Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. [1.0]. Lyon, France: IARC; 2001.
2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J: Cancer Incidence in Five Continents, vol VIII. Lyon: IARC Press; 1997.
3. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, et al.: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993, 85:1819-1827.
4. Geddes M, Parkin DM, Khlat M, Balzi D, Buiatti E: Cancer in Italian Migrants Populations. Lyon: IARC; 1993. (IARC Scientific Publication No. 123.)
5. Tyczynski J, Tarkowski W, Parkin DM, Zatonski W: Cancer mortality among polish migrants to Australia. Eur J Cancer 1994, 30A:478-484.
6. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (eds): SEER Cancer Statistics Review, 1975-2001. Bethesda: National Cancer Institute; 2004.
7. Sankaranarayanan R, Parkin DM, Black RJ: Cancer Survival in Developing Countries. Lyon: IARC; 1998.
8. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003, 14 Suppl 5:V128-V149.
9. Peto R, Boreham J, Clarke M, Davies C, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000, 355:1822.
10. Bray F, Sankila R, Ferlay J, Parkin DM: Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002, 38: 99-166.
11. Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1988, 48:246-253.
12. Moolgavkar SH, Stevens RG, Lee JA: Effect of age on incidence of breast cancer in females. J Natl Cancer Inst 1979, 62:493-501.
13. European Network of Cancer Registries: EUROCIM Version 4.0. Lyon: European Network of Cancer Registries; 2001.
14. Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003, 39:1718-1729.
15. Nab HW, Mulder PG, Crommelin MA, van der Heijden LH, Coebergh JW: Is the peak in breast cancer incidence in sight? A study conducted in the southeastern Netherlands. Eur J Cancer 1994, 30A: 50-52.
16. Quinn M, Allen E: Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. BMJ 1995, 311:1391-1395.
17. Persson I, Bergstrom R, Barlow L, Adami HO: Recent trends in breast cancer incidence in Sweden. Br J Cancer 1998, 77: 67-169.
18. Cancer Registry of Norway: Cancer in Norway; 2000. Oslo: Cancer Registry of Norway (Kreftregisteret); 2003.
19. Zahl PH, Strand BH, Maehlen J: Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004, in press.
20. Zaridze DG, Basieva TH: Incidence of cancer of the lung, stomach, breast, and cervix in the USSR: pattern and trends. Cancer Causes Control 1990, 1:39-40.
21. Stevens RG, Moolgavkar SH, Lee JAH: Temporal trends in breast cancer. Am J Epidemiol 1982, 115:759-777.
22. Ewertz M, Carstensen B: Trends in breast cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988, 41: 6-51.
23. Rostgaard K, Vaeth M, Holst H, Madsen M, Lynge E: Age-period-cohort modelling of breast cancer incidence in the Nordic countries. Stat Med 2001, 20:47-61.
24. Tretli S, Gaard M: Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of World War II in Norway. Cancer Causes Control 1996, 7:507-512.
25. Persson I, Bergstrom R, Sparen P, Thorn M, Adami HO: Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort. Br J Cancer 1993, 68:1247-1253.
26. Walter SD, Day NE: Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol 1983, 118: 865-886.
27. Hermon C, Beral V: Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer 1996, 73: 955-960.
28. Peto R: Mortality from breast cancer in UK has decreased suddenly. BMJ 1998, 317:476-477.
29. Bornefalk A, Persson I, Bergstrom R: Trends in breast cancer mortality among Swedish women 1953-92: analyses by age, period and birth cohort. Br J Cancer 1995, 72:493-497.
30. Lacey JV Jr, Devesa SS, Brinton LA: Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 2002, 39: 82-88.
31. Wun LM, Feuer EJ, Miller BA: Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 1995, 6: 35-144.
32. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK: Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003, 95:1276-1299.
33. MacMahon B: Temporal trends in breast cancer incidence. Am J Epidemiol 1982, 116:867.
34. Smigel K: Breast cancer death rates decline for white women [news]. J Natl Cancer Inst 1995, 87:173.
35. National Cancer Institute of Canada: Canadian Cancer Statistics 1998. National Cancer Institute of Canada; 1998.
36. Holford TR, Roush GC, McKay LA: Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol 1991, 44:29-39.
37. Tarone RE, Chu KC, Gaudette LA: Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada J Natl Cancer Inst 1997, 89:251-256.
38. Giles GG, Amos A: Evaluation of the organised mammographic screening programme in Australia. Ann Oncol 2003, 14: 209-1211.
39. Armstrong W, Borman B: Breast cancer in New Zealand: trends, patterns, and data quality. N Z Med J 1996, 109: 21-224.
40. Smith CL, Kricker A, Armstrong BK: Breast cancer mortality trends in Australia: 1921 to 1994. Med J Aust 1998, 168: 1-14.
41. Hermon C, Beral V: Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. Br J Cancer 1996, 73: 955-960.
42. Wakai K, Suzuki S, Ohno Y, Kawamura T, Tamakoshi A, Aoki R: Epidemiology of breast cancer in Japan. Int J Epidemiol 1995, 24:285-291.
43. Nagata C, Kawakami N, Shimizu H: Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 1997, 44:75-82.
44. Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S: The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 2004, 108: 01-906.
45. Parkin DM: Cancer in developing countries. Cancer Surveys 1994, 19/20:519-561.
46. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H: Trends in Cancer Incidence and Mortality. Lyon: IARC; 1993.
47. Yeole BB, Kurkure AP: An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pac J Cancer Prev 2003, 4:51-56.
48. Seow A, Duffy SW, McGee MA, Lee J, Lee HP: Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol 1996, 25:40-45.
49. Yang L, Parkin DM, Li L, Chen Y: Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003, 106: 71-783.
50. Chie WC, Chen CF, Lee WC, Chen C J, Lin RS: Age-period-cohort analysis of breast cancer mortality. Anticancer Res 1995, 15:511-515.
51. Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PS, Lau EM, Wong CM: Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer 2002, 87:982-988.
52. Echimane AK, Ahnoux AA, Adoubi I, Hien S, M'Bra K, D'Horpock A, Diomande M, Anongba D, Mensah-Adoh I, Parkin DM: Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995-1997. Cancer 2000, 89:653-663.
53. Chokunonga E, Levy LM, Bassett MT, Mauchaza BG, Thomas DB, Parkin DM: Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 2000, 85:54-59.
54. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, Whelan SL: Cancer in Africa: Epidemiology and Prevention Lyon: IARC; 2003.
55. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S: Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000, 82:1585-1592.
56. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 1983, 303:767-770.
57. Lane-Claypon JE: A Further Report on Cancer of the Breasts, with Special Reference to its Associated Antecedent Conditions London: HMSO; 1926. (Report on Public Health and Medical Subjects No. 32.)
58. Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
59. Heck KE, Pamuk ER: Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol 1997, 145:366-372.
60. Adams J, White M, Forman D: Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. BMJ doi:10.1136/bmj.38114.679387.AE (published 2 June 2004).
61. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996, 347:1713-1727.
62. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975, 15:617-631.
63. Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S, Howe GR, et al.: Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med 1996, 334:356-361.
64. Smith-Warner SA, Spiegelman D, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, et al.: Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 2001, 92:767-774.
65. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO: Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998, 76:29-34.
66. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO: Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001, 91:421-430.
67. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, et al.: Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002, 87:1234-1245.
68. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R: Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 1998, 27:735-742.
69. International Agency for Research on Cancer: Breast Cancer Screening. Lyon: IARC Press; 2002.
70. McCann J, Stockton D, Day N: Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998, 5:42-48.
71. Hakama M, Pukkala E, Heikkila M, Kallio M: Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997, 314:864-867.
72. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992, 30:187-210.
73. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK: Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer 1999, 81: 77-880.
74. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000, 321:665-669.
75. Jatoi I, Miller AB: Why is breast-cancer mortality declining? Lancet Oncol 2003, 4:251-254.
76. Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG: American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol 1999, 17:1939-1955.
77. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 1998, 351:1451-1467.
78. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK: Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996, 88:1571-1579.
79. Peto R: Five years of tamoxifen - or more? J Natl Cancer Inst 1996, 88:1791-1793.
80. Selby P, Gillis C, Haward R: Benefits from specialised cancer care. Lancet 1996, 348:313-318.
81. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002, 360:187-195.
82. Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P: Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003, 361:296-300.
83. Cuzick J: Aromatase inhibitors in prevention - data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). Recent Results Cancer Res 2003, 163:96-103.
84. Feigelson HS, Henderson BE: Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention. Breast Cancer Res 2000, 2:277-282.
85. van Geel AN: Prophylactic mastectomy: the Rotterdam experience. Breast 2003, 12:357-361.